| http://purl.uniprot.org/citations/32777482 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/32777482 | http://www.w3.org/2000/01/rdf-schema#comment | "Angiopoietin like protein 3 (ANGPTL3) is best known for its function as an inhibitor of lipoprotein and endothelial lipases. Due to the capacity of genetic or pharmacologic ANGPTL3 suppression to markedly reduce circulating lipoproteins, and the documented cardioprotection upon such suppression, ANGPTL3 has become an emerging therapy target for which both antibody and antisense oligonucleotide (ASO) therapeutics are being clinically tested. While the antibody is relatively selective for circulating ANGPTL3, the ASO also depletes the intra-hepatocellular protein, and there is emerging evidence for cell-autonomous functions of ANGPTL3 in the liver. These include regulation of hepatocyte glucose and fatty acid uptake, insulin sensitivity, LDL/VLDL remnant uptake, VLDL assembly/secretion, polyunsaturated fatty acid (PUFA) and PUFA-derived lipid mediator content, and gene expression. In this review we elaborate on (i) why ANGPTL3 is considered one of the most promising new cardiometabolic therapy targets, and (ii) the present evidences for its intra-hepatocellular or cell-autonomous functions."xsd:string |
| http://purl.uniprot.org/citations/32777482 | http://purl.org/dc/terms/identifier | "doi:10.1016/j.bbalip.2020.158791"xsd:string |
| http://purl.uniprot.org/citations/32777482 | http://purl.uniprot.org/core/author | "Jauhiainen M."xsd:string |
| http://purl.uniprot.org/citations/32777482 | http://purl.uniprot.org/core/author | "Olkkonen V.M."xsd:string |
| http://purl.uniprot.org/citations/32777482 | http://purl.uniprot.org/core/author | "Ruhanen H."xsd:string |
| http://purl.uniprot.org/citations/32777482 | http://purl.uniprot.org/core/author | "Haridas P.A.N."xsd:string |
| http://purl.uniprot.org/citations/32777482 | http://purl.uniprot.org/core/date | "2020"xsd:gYear |
| http://purl.uniprot.org/citations/32777482 | http://purl.uniprot.org/core/name | "Biochim Biophys Acta Mol Cell Biol Lipids"xsd:string |
| http://purl.uniprot.org/citations/32777482 | http://purl.uniprot.org/core/pages | "158791"xsd:string |
| http://purl.uniprot.org/citations/32777482 | http://purl.uniprot.org/core/title | "Angiopoietin-like protein 3, an emerging cardiometabolic therapy target with systemic and cell-autonomous functions."xsd:string |
| http://purl.uniprot.org/citations/32777482 | http://purl.uniprot.org/core/volume | "1865"xsd:string |
| http://purl.uniprot.org/citations/32777482 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/32777482 |
| http://purl.uniprot.org/citations/32777482 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/32777482 |
| http://purl.uniprot.org/uniprot/#_A8K061-mappedCitation-32777482 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/32777482 |
| http://purl.uniprot.org/uniprot/#_Q9Y5C1-mappedCitation-32777482 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/32777482 |
| http://purl.uniprot.org/uniprot/Q9Y5C1 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/32777482 |
| http://purl.uniprot.org/uniprot/A8K061 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/32777482 |